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Case Report
Papillary glioneuronal tumor radiologically 
mimicking a cavernous hemangioma with 
hemorrhagic onset
Anna Maria Buccoliero,1 Flavio Giordano,3 Federico Mussa,3 Antonio Taddei,2 Lorenzo Genitori3 
and Gian Luigi Taddei1
Departments of 1Human Pathology and Oncology and 2General Surgery, University of Florence and 3Division of 
Neurosurgery, ‘Anna Meyer’ Pediatric Hospital, Florence, Italy
Papillary glioneuronal tumor is a recently identified
low-grade brain neoplasm classified as variant of gan-
glioglioma. Its salient morphological characteristics are the
presence of pseudopapillary structures composed of blood
vessels, often hyalinized, lined by uniform small astrocytes
and a proliferation of neurocytic cells, eventually admixed
with ganglioid and ganglion cells. We present a case of pap-
illary glioneuronal tumor occurring in a 15-year-old female
with an unusual hemorrhagic onset. The clinical, morpho-
logical and immunohistochemical features are discussed
and the published literature is reviewed. This article pro-
poses that papillary glioneuronal tumor should be included
in the differential diagnosis of patients with tumoral
related brain hemorrhage.
Key words: central nervous system, immunohistochemis-
try, intracerebral hemorrhage, mixed neuronal-glial
tumors, papillary glioneuronal tumor.
INTRODUCTION
Mixed glio-neuronal tumors represent a group of brain
neoplasms showing a wide morphological, immuno-
histochemical and ultrastructural spectrum of glial and
neuronal differentiation. They especially occur in the
supratentorial region of young people and often have an
indolent prognosis. Among them, the papillary glioneu-
ronal tumor has recently been identified as an infrequent
low-grade tumor and classified as a variant of gan-
glioglioma. Typical morphological features are pseud-
opapillary structures composed of frequently thickened
hyalinized blood vessels lined by uniform small astrocytes
and a proliferation of neurocytic cells eventually admixed
with ganglioid and ganglion cells. Rabdoid, minigemisto-
cytic, and Olig2 (a recently established oligodendroglial
marker) positive cells have been recognized too.1–16
In this article, we describe the clinical, morphological
and immunohistochemical features of a new case of papil-
lary glioneuronal tumor diagnosed in a young girl.
CASE REPORT
Clinical summary
MB, a previously healthy 15-year-old girl, was admitted
to the intensive care unit (ICU) because of a sudden
headache followed by aphasia and coma. First, computed
tomography (CT) showed a massive intraparenchymal
brain hemorrhage located in the left basal ganglia and tem-
poral lobe with intraventricular bleeding and hydroceph-
alus (Fig. 1). Emergency external ventricular drainage was
performed to treat the hydrocephalus and raised intracra-
nial pressure. Cerebral angiography revealed no abnormal
vascular circles, while T1–T2-weighed magnetic resonance
imaging (MRI) supported the diagnosis of cavernous
hemangioma. Shortly afterwards the brain hemorrhage
spontaneously healed without further surgery. The patient
was transferred to the ward and discharged 20 days later
free of neurological complaints. The lesion was not oper-
ated on because of its deep and inaccessible site. During
the follow-up, serial CT and MRI revealed a progressive
cystic transformation of the hemorrhage cavity into the left
temporal lobe extending in the region of the homolateral
thalamus. The final radiological picture, 2 years later, con-
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sisted of a cystic-nodular lesion located in the deep left
temporal lobe in the paraventricular region; the maximum
diameter of the cystic lesion was about 35 mm, while the
nodular one was about 25 mm. Contrast enhancement was
nodular and showed only a small solid circular part of the
lesion. The new radiological diagnosis was consistent with a
brain tumor or vascular malformation, such as hemangio-
blastoma or cavernous hemangioma (Fig. 2).
Surgery was computer-assisted by Neuronavigator
(Stealth Navigation System, Medtronic, Goleta, California,
USA) after a previous brain-map of eloquent areas
obtained with functional MRI. Gross total removal was
achieved through a left parieto-occipital transventricular
route. The postoperative period was uneventful. The
patient was discharged from the ICU to the ward in 1-day
surgery with normal neurological examination. Postopera-
tive CT control confirmed radical removal without abnor-
mal contrast enhancement. Thirty-two months after the
first symptoms and 12 months after the surgery the patient
is alive and well.
Pathological findings
Methods
Surgical samples were routinely fixed in neutral buffered
formol, embedded in paraffin and stained with HE
for histopathological evaluation. Immunohistochemical
studies (standard Streptavidin-biotin technique) were per-
formed. The primary antibodies used were: monoclonal
antibody directed against KI-67 (clone Mib-1, 1:80 dilu-
tion; IMMUNOTECH, Marseille, France), GFAP (clone
ZCG29, prediluted, Zymed Laboratory, San Francisco,
California, USA), neuron specific enolase (NSE; clone
MIG-N3, prediluted, BioGenex, San Ramon, California,
USA), synaptophysin (SP; clone Snp 88, prediluted, Bio-
Genex) and antibody against neurofilaments (NF; PAN
clone DA2; FNP7; RMb020.11, 1:20 dilution, Zymed Lab-
oratory). Microwave antigen enhancement was utilized for
all the used antibodies. Immunohistochemical staining was
performed on NEXES automated immunostainer (Ven-
tana Medical Systems, Tucson, Arizona, USA).
The proliferation index was determined estimating the
percentage of the Ki-67 positive neoplastic cells in the total
tumoral cells in the most positive areas.
Fig. 1 First computed tomography (CT): massive intra-
parenchymal brain hemorrhage located in the left basal
ganglia and temporal lobe with intraventricular bleeding and
hydrocephalus.
Fig. 2 Axial (right) and coronal (left)
MRI of the lesion before its surgical
excision. The cystic-nodular tumor was
paraventricular, located in the left deep
temporal lobe and posterior thalamus;
homogeneous gadolinium enhance-
ment is seen in the nodular part.
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Fig. 3 Histological and immunohistochemical features: (a–d) double architectural patterns, pseudopapillae composed of thick-
ened and hyalinized blood vessels sheathed by a single or multistratified layer of small cells and solid areas consisted of neurocytic
cells; (c,d) thin walled vessels; and (d) microcalcifications in the solid areas (HE; original magnification: a ×100; b–d ×200); GFAP
(e, pseudopapillary and solid areas) and SP (f, solid areas only) positive immuno-stain (original magnification: e,f ×200).
Papillary glioneuronal tumor 209
© 2006 Japanese Society of Neuropathology
Results
Histological examination of the tumor revealed two
different architectural patterns: pseudopapillary and solid.
Pseudopapillae were composed of blood vessels, often
thickened and hyalinized, sheathed by a single or multi-
stratified layer of uniform small cells with ovoid-round
nuclei and scant cytoplasm; solid areas consisted of isomor-
phous cells with round nuclei and wide, clear cytoplasm
mimicking oligodendroglioma or neurocytoma. Thin
walled vessels were numerous in the solid areas. Lympho-
cytic infiltrates, microcalcifications, hemosiderin deposits
and microhemorrhagic areas were observed. The lesion did
not show necrosis or mitoses. Reactive pilocytic gliosis with
Rosenthal fiber and granular bodies, and wide cicatricial
fibrous areas were identified along the peritumoral tissue
(Fig. 3).
Immunohistochemical examination revealed both neu-
ronal and glial differentiation. Specifically, the cells lining
the pseudopapillae and the oligodendrocyte-like cells
stained positively for GFAP, NSE and NF whereas the
oligodendrocyte-like cells only stained positively for SP
(Fig. 3).
The Ki-67 index was very low (about 1%).
Table 1 Papillary glioneuronal cases reported in the international Literature
Reference Sex/
age
Symptoms/duration Site/size (cm)† Neuroimaging characteristics Therapy‡ Follow-up§/
monthsLesion Enhancement 
pattern
Komori 1998 M/13 Headache, nausea, 
memory loss, difficulty
in comprehension and
expression/8 months
Temporal left/7 Cystic with mural
nodule,
calcifications
Heterogeneous GTR NER/45
F/30 None Parietal left/3 Solid and cystic Heterogeneous GTR NER/43
M/11 Seizure/1 day Temporal left/7 Cystic, calcifications Ring enhancement PR RT NER/12
F/27 Seizure/1 day Temporal right/4 Solid and cystic,
calcifications
Homogenous GTR NER/18
M/36 Headache, transient 
visual field, impaired 
speech and
comprehension/
1 years
Parietal left/7 Cystic with mural
nodule
Homogenous GTR NER/6
F/19 Mood swings, impaired
comprehension and 
expression/2 years
Temporal left/1.5 Solid Equivocal GTR NER/12
F/35 Seizure, headache/1 day Temporal left/4 Solid and cystic,
calcifications
Ring enhancement GTR NER/12
M/52 Headache/6 months Frontal right/3 Cystic with mural
nodule
Homogeneous GTR NER/6
F/26 Headache, tingling on
the rightside/1 day
Frontal left/5 Cystic with mural
nodule
Homogeneous GTR NER/?
Bouvier-Labit
2000
M/23 Headache, visual 
disturbance,
dorsalgias, impaired
comprehension and 
expression/4 weeks
Parieto-occipital
left/6
Cystic with mural
nodule
Heterogeneous GTR NER/84
Prayson 2000 M/18 Headache, visual 
disturbance/2 months
Parieto-occipital
left/5.3
Cystic Ring enhancement,
scattered internal
enhancement
GTR NER/3
Barnes 2002 M/4 Headache/6 months Temporal left/3 Solid Heterogeneous GTR NER/30
Broholm 2002 M/16 Consciousness lost, 
seizures/7 months
Frontal left/2.8 Cystic with mural
nodule
Ring enhancement,
mural nodule
enhancement
GTR NER/6
Tsukayama 
2002
F/75 Vertigo, vomiting/
unclear
Frontal left/5 Cystic with mural
nodule
Homogeneous PR NER/20
Lamszus 2003 F/24 Seizures/6 months Parieto-occipital
left/1
Cystic Absent GTR NER/3
Borges 2004 F/14 Headache, decrease 
in musclestrength, 
seizure/18 months
Fronto-parietal
left/5.5
Cystic Ring enhancement GTR NER/56
Stosic-Opincal
2005
F/16 Nausea, vomiting, fever,
headache/unclear
Parietal right/3.5 Cystic Ring enhancement
and septations
PR NER/36
†Greatest dimension
GTR, gross total resection; NER, no evidence of recurrence; PR, partial resection.
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DISCUSSION
Papillary glioneuronal tumor is a low-grade uncommon
neoplasm recently listed as a rare variant of ganglioglioma
in the World Health Organization (WHO) classification of
tumors of the nervous system.1 It has been named in this
way because of its papillary feature (due to the dehiscence
of the cells about the vessels) and because of its double
astrocytic and neuronal differentiation at either the mor-
phological, immunohistochemical or ultrastructural level.
Papillary glioneuronal tumor was first described by
Komori et al. in 1998 as a novel clinico-pathologic entity.2
Nevertheless, morphologically similar tumors have been
previously reported under many different names, i.e.
pseudopapillary neurocytoma with glial differentiation,
atypical extraventricular neurocytic neoplasm and pseudo-
papillary ganglioneurocytoma.17–24
To the best of our knowledge, 17 cases complete with
clinical and histopathological data have been documented
to date in the English language literature (one additional
case lacked exhaustive clinical and histopathological data;
six cases were reported in the Polish and Japanese litera-
ture).2–12,15,16,24–26 The analysis of these cases supports the
proposition that papillary glioneuronal tumor more often
affects young people (mean age at the diagnosis: 26 years,
range 4–75 years) without gender predominance (female :
male ratio about 1:1). The first symptoms, commonly head-
ache (59%) and seizures (35%), appear an average of
6 months (range 1 day-2 years) before diagnosis. It typi-
cally arises in the supratentorial region (all reported cases)
primarily involving the left cerebral hemispheres (82%).
Common neuroimaging characteristics are a cystic appear-
ance (88%) and the presence of contrast enhancement
(88%; ring enhancement 35%; homogeneous 29%; heter-
ogeneous 24%). Follow-up data indicate a benign outcome
with no evidence of recurrence during intervals ranging
from 3 months to 7 years (Table 1).2–12,15 Histopathological
features of papillary glioneuronal tumor are similar in all
reported cases, invariably reproducing the first description
of this tumor by Komori.2
The main peculiarity of our case is the onset with a mas-
sive brain hemorrhage.
The frequency of intracranial hemorrhage in patients
with intracranial neoplasms varies in the different series
from 2% to 5%. It may occur in all central nervous system
tumors to a varying degree and extent and may even be
massive. These massive ones mostly occur in more malig-
nant tumors, such as glioblastoma or metastases. Neverthe-
less, benign tumors, such as pituitary adenoma, pilocytic
astrocytomas or meningiomas, may also bleed to the extent
of a massive hemorrhage.27–31
Several mechanisms were advocated to explain the
pathogenesis of brain tumor related hemorrhages: endot-
helial proliferation with subsequent obliteration of the
lumen; thin walled or poorly formed vessels; perivascular
necrosis with subsequent loss of vessel support; presence of
intratumoral arteriovenous fistulae.30,31
In the present case, the hemorrhage could have resulted
either from the presence of numerous thin walled vessels
in the solid areas or from the abnormal hyalinized wall of
the vessels in the papillary zones. Actually, in spite of an
absence of previously reported papillary glioneuronal
tumors showing massive brain hemorrhages, signs of pre-
vious bleeding (i.e., hemosiderin deposition, hemosiderin-
laden macrophages) are often reported.2–5,8 Consequently,
we may suppose that hemorrages may occur with various
gravity in papillary glioneuronal tumor.
In conclusion, papillary glioneuronal tumor should be
included in the differential diagnosis of patients with
tumoral related brain hemorrhage.
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